DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 62 filers reported holding DERMA SCIENCES INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $18,000 | +12.5% | 3,494 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +14.3% | 3,494 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | +16.7% | 3,494 | -10.0% | 0.00% | – |
| Q1 2016 | $12,000 | -33.3% | 3,882 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | 0.0% | 3,882 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -33.3% | 3,882 | +4.5% | 0.00% | – |
| Q2 2015 | $27,000 | -95.8% | 3,714 | -95.1% | 0.00% | -100.0% |
| Q1 2015 | $646,000 | -8.2% | 76,216 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $704,000 | +11.9% | 75,613 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $629,000 | -26.0% | 75,511 | +2.7% | 0.00% | 0.0% |
| Q2 2014 | $850,000 | -2.0% | 73,523 | +7.5% | 0.00% | 0.0% |
| Q1 2014 | $867,000 | +72.4% | 68,388 | +47.1% | 0.00% | 0.0% |
| Q4 2013 | $503,000 | -14.9% | 46,487 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $591,000 | -4.7% | 47,768 | +2.9% | 0.00% | 0.0% |
| Q2 2013 | $620,000 | – | 46,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 373,918 | $2,677,000 | 2.26% |
| Perceptive Advisors | 348,784 | $24,997,000 | 1.50% |
| Consonance Capital Management LP | 1,760,649 | $12,606,000 | 1.27% |
| Broadfin Capital, LLC | 2,317,489 | $16,593,000 | 0.89% |
| GREAT POINT PARTNERS LLC | 280,000 | $2,005,000 | 0.78% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 300,000 | $2,148,000 | 0.75% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 273,926 | $1,961,000 | 0.63% |
| Senvest Management, LLC | 1,152,626 | $8,253,000 | 0.52% |
| J. Goldman & Co LP | 622,500 | $4,457,000 | 0.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 968,881 | $6,937,000 | 0.23% |